Liu Hui, Chen Shuxiang, Liu Xin, Lou Jinli
Clinical Laboratory Center, Beijing Youan Hospital, Capital Medical University, 100069, Beijing, China.
Virol J. 2024 Apr 23;21(1):92. doi: 10.1186/s12985-024-02366-2.
Occult HBV infection (OBI) is a special form of hepatitis B virus (HBV) infection that may cause Liver cirrhosis and hepatocellular carcinoma, causing significant harm to patients. Given the insidious nature of OBI, it is usually not easy to be detected. Most of the samples currently studied are concentrated on blood donors, however, patients in this special state have not been fully studied. This project aimed to study the effect of HBV S region mutations on HBsAg in patients with clinical OBI.
Collect 107 HBsAg-/HBV DNA + blood samples from Beijing Youan Hospital, Capital Medical University from August 2022 to April 2023. Next, the successfully extracted and amplified HBV DNA S regions were sequenced. Construct mutant plasmids to verify the cell function of the high-frequency mutation sites and explore the possible molecular mechanism.
Sixty-eight HBsAg-negative samples were sequenced, revealing high-frequency amino acid substitution sites in the HBV S protein, including immune escape mutations (i.e., sY100C、sK122R、sI126T、sT131P、and sS114T) and TMD (Transmembrane domain) region substitutions (i.e., sT5A、sG10D、sF20S、and sS3N). We constructed a portion of the mutant plasmids and found that sT5A, sF20S, sG10D, sS3N, sI68T, and sI126T single point mutations or combined mutations may decrease HBsAg expression or change the antigenicity of HBsAg leading to detection failure.
HBsAg-negative patients may show various mutations and amino acid replacement sites at high frequency in the HBV S-region, and these mutations may lead to undetectable Hepatitis B surface antigen (HBsAg), HBsAg antigenic changes or secretion inhibition.
隐匿性乙型肝炎病毒感染(OBI)是乙型肝炎病毒(HBV)感染的一种特殊形式,可能导致肝硬化和肝细胞癌,对患者造成严重危害。鉴于OBI的隐匿性,通常不易被检测到。目前研究的大多数样本集中在献血者身上,然而,处于这种特殊状态的患者尚未得到充分研究。本项目旨在研究临床OBI患者中HBV S区突变对HBsAg的影响。
收集2022年8月至2023年4月首都医科大学附属北京佑安医院的107份HBsAg阴性/HBV DNA阳性血液样本。接下来,对成功提取和扩增的HBV DNA S区进行测序。构建突变体质粒以验证高频突变位点的细胞功能,并探索可能的分子机制。
对68份HBsAg阴性样本进行测序,揭示了HBV S蛋白中的高频氨基酸替代位点,包括免疫逃逸突变(即sY100C、sK122R、sI126T、sT131P和sS114T)和跨膜结构域(TMD)区域替代(即sT5A、sG10D、sF20S和sS3N)。我们构建了部分突变体质粒,发现sT5A、sF20S、sG10D、sS3N、sI68T和sI126T单点突变或联合突变可能会降低HBsAg表达或改变HBsAg抗原性,导致检测失败。
HBsAg阴性患者的HBV S区可能出现各种高频突变和氨基酸替代位点,这些突变可能导致乙型肝炎表面抗原(HBsAg)检测不到、HBsAg抗原性改变或分泌抑制。